Effectiveness and Safety of Newer Antidiabetic Medications for Ramadan Fasting Diabetic Patients - Wikidata - awgldk - TriplyDB

Effectiveness and Safety of Newer Antidiabetic Medications for Ramadan Fasting Diabetic Patients

Effectiveness and Safety of Newer Antidiabetic Medications for Ramadan Fasting Diabetic Patients

http://www.wikidata.org/entity/Q28067209

about

Initial increase in glucose variability during Ramadan fasting in non-insulin-treated patients with diabetes type 2 using continuous glucose monitoring

P2860

Q57784677-8CC5111D-1AE4-4A3A-9AF0-F2077D1DA7CC

P2860

Effectiveness and Safety of Newer Antidiabetic Medications for Ramadan Fasting Diabetic Patients

http://www.wikidata.org/entity/Q28067209

description

2016 nî lūn-bûn

@nan

2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Effectiveness and Safety of Ne ...... adan Fasting Diabetic Patients

@ast

Effectiveness and Safety of Ne ...... adan Fasting Diabetic Patients

@en

Effectiveness and Safety of Ne ...... adan Fasting Diabetic Patients

@nl

type

label

Effectiveness and Safety of Ne ...... adan Fasting Diabetic Patients

@ast

Effectiveness and Safety of Ne ...... adan Fasting Diabetic Patients

@en

Effectiveness and Safety of Ne ...... adan Fasting Diabetic Patients

@nl

prefLabel

Effectiveness and Safety of Ne ...... adan Fasting Diabetic Patients

@ast

Effectiveness and Safety of Ne ...... adan Fasting Diabetic Patients

@en

Effectiveness and Safety of Ne ...... adan Fasting Diabetic Patients

@nl

P1433

Q28067209-ADEA3012-B33D-486B-9396-F39019399C21

P1476

Q28067209-F29061E6-5EF3-41D2-B06E-831E96672E6C

P2093

Q28067209-851A18F1-8EB8-4F0E-BB0A-96E62F24FF26

P275

Q28067209-DFCFD04A-F400-4F6B-BC68-13BD162B00B6

P2860

Q28067209-0911261D-9012-4D77-ACC7-B5D75AC93BE7

Q28067209-1751BB25-6B10-4BBB-AED5-747F459638E9

Q28067209-19323E0C-88B3-49E4-BEDD-A9E5422265C7

Q28067209-1CA17D27-00DC-499E-9E10-A7DEFD962F09

Q28067209-20D3C0EE-146F-44BB-A513-0917734B61DE

Q28067209-28D8EFAC-D45D-4C54-A771-1DE3D0C2E2A2

Q28067209-2C2828D4-07C3-4A96-9784-1744FA7AC8BE

Q28067209-30888790-1E6A-4793-B053-059E376E9006

Q28067209-308F029A-87C2-4C69-B0F7-6F4B10C475AC

Q28067209-344839E3-29A3-4264-A169-B95201AD5501

P304

Q28067209-7C5EF886-F140-42F7-9546-E1A52DB197E4

P31

Q28067209-451F4C2B-C7BA-4434-909E-AF307349CEEC

Q28067209-937A184A-78DC-4EAF-A8AB-1132CE3EDD47

P3181

Q28067209-45158E68-7507-434E-928F-01909BE3272F

P356

Q28067209-FD1452F4-D69A-4992-A969-7E10B0B9F861

P407

Q28067209-F7895E03-EC86-4696-A626-E14241153B30

P478

Q28067209-0F10DD92-C52E-4C99-9FC3-53A87DB62C38

P50

Q28067209-07E091CC-BF42-4EAF-A3E5-48956CD6DAE0

P5008

Q28067209-248307F1-9C6F-4951-96F9-AC9F1399D975

P577

Q28067209-A66338FD-8D5E-467C-9636-5E823A310F68

Q28067209-AE9F112E-84E8-49DC-B33B-38BB8387EB32

P698

Q28067209-8D203151-D543-4598-862C-335B04057026

P921

Q28067209-15545B3B-69AD-493C-9E4F-0DFCE6475FF7

Q28067209-3D789C61-039E-4533-ABA9-66C72AF36331

Q28067209-4D5E23F9-C6F4-4566-B24E-CE1481FB9AB7

Q28067209-54AF82D0-2734-448C-B6FB-32B9D4C4E6B8

Q28067209-94D4CFBB-BD39-4D40-9E97-2F040072633F

P932

Q28067209-0FE53BE9-AD9B-409B-B6E8-2154B1A814E4

P3181

P356

P1433

Journal of Diabetes Research

P1476

Effectiveness and Safety of Ne ...... adan Fasting Diabetic Patients

@en

P2093

Ehab Mudher Mikhael

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

GLP-1 receptor agonists: a review of head-to-head clinical studies

Effects on health of fluid restriction during fasting in Ramadan

Long-term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add-on therapy to metformin in patients with type 2 diabetes: 4-year data.

A double-blind, randomized trial, including frequent patient-physician contacts and Ramadan-focused advice, assessing vildagliptin and gliclazide in patients with type 2 diabetes fasting during Ramadan: the STEADFAST study.

The effect of vildagliptin relative to sulphonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: the VIRTUE study.

Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 study.

Ramadan and diabetes: As-Saum (The fasting).

The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial.

Diabetic emergencies including hypoglycemia during Ramadan

Vildagliptin vs sulfonylurea in Indian Muslim diabetes patients fasting during Ramadan

P304

6962574

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3901003

http://www.w3.org/2001/XMLSchema#string

P356

10.1155/2016/6962574

http://www.w3.org/2001/XMLSchema#string

P407

P478

2016

http://www.w3.org/2001/XMLSchema#string

P50

Ehab Mudher Mikhael

P5008

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2016-08-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27642611

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

mechanism of action

maturity-onset diabetes of the young

physiological phenomena

P932

5013205

http://www.w3.org/2001/XMLSchema#string